BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fallahi P, Ferrari SM, Galdiero MR, Varricchi G, Elia G, Ragusa F, Paparo SR, Benvenga S, Antonelli A. Molecular targets of tyrosine kinase inhibitors in thyroid cancer. Semin Cancer Biol 2020:S1044-579X(20)30249-2. [PMID: 33249201 DOI: 10.1016/j.semcancer.2020.11.013] [Cited by in Crossref: 23] [Cited by in F6Publishing: 28] [Article Influence: 7.7] [Reference Citation Analysis]
Number Citing Articles
1 Hu X, Xu W, Liu Y, Guo H. Visible Light-Induced Diastereoselective Construction of Trifluoromethylated Cyclobutane Scaffolds through [2+2]-Photocycloaddition and Water-Assisted Hydrodebromination. J Org Chem 2023. [PMID: 36701662 DOI: 10.1021/acs.joc.2c02976] [Reference Citation Analysis]
2 Wang X, Zhang C, Song H, Yuan J, Zhang L, He J. CircCCDC66: Emerging roles and potential clinical values in malignant tumors. Front Oncol 2022;12:1061007. [PMID: 36698408 DOI: 10.3389/fonc.2022.1061007] [Reference Citation Analysis]
3 Amrillaeva V, Dralle H, Weber F, Deneken F, Farzaliyev F. The internal mammary artery perforator flap for neck reconstruction after palliative resection of advanced anaplastic thyroid cancer: a case report. J Med Case Rep 2023;17:8. [PMID: 36624449 DOI: 10.1186/s13256-022-03712-0] [Reference Citation Analysis]
4 Elia G, Patrizio A, Ragusa F, Paparo SR, Mazzi V, Balestri E, Botrini C, Rugani L, Benvenga S, Materazzi G, Spinelli C, Antonelli A, Fallahi P, Ferrari SM. Molecular features of aggressive thyroid cancer. Front Oncol 2022;12:1099280. [PMID: 36605433 DOI: 10.3389/fonc.2022.1099280] [Reference Citation Analysis]
5 Li Y, Luo Z, Wang X, Zhang S, Hei H, Qin J. Design of new drugs for medullary thyroid carcinoma. Front Oncol 2022;12:993725. [PMID: 36544713 DOI: 10.3389/fonc.2022.993725] [Reference Citation Analysis]
6 Ren X, Du H, Cheng W, Wang Y, Xu Y, Yan S, Gao Y. Construction of a ferroptosis-related eight gene signature for predicting the prognosis and immune infiltration of thyroid cancer. Front Endocrinol 2022;13. [DOI: 10.3389/fendo.2022.997873] [Reference Citation Analysis]
7 Liu Y, Liu C, Pan Y, Zhou J, Ju H, Zhang Y. Pyruvate carboxylase promotes malignant transformation of papillary thyroid carcinoma and reduces iodine uptake. Cell Death Discov 2022;8:423. [PMID: 36266265 DOI: 10.1038/s41420-022-01214-y] [Reference Citation Analysis]
8 Liu J, Cai H, Yi H, Li X, Peng Y, Li L, Li T. Influence of Dehydroxymethylepoxyquinomicin on Radiosensitivity of Thyroid Carcinoma TPC-1 Cells. Journal of Oncology 2022;2022:1-9. [DOI: 10.1155/2022/5026308] [Reference Citation Analysis]
9 Wang L, Deng X, Chen Y, Zhao Y, Li Z, Shi Z. PRR15 Is a Novel Diagnostic and Prognostic Biomarker in Papillary Thyroid Cancer and Modulates the Tumor Microenvironment. Journal of Oncology 2022;2022:1-11. [DOI: 10.1155/2022/3290479] [Reference Citation Analysis]
10 Li J, Zhang Y, Sun F, Xing L, Sun X. Towards an era of precise diagnosis and treatment: Role of novel molecular modification-based imaging and therapy for dedifferentiated thyroid cancer. Front Endocrinol 2022;13:980582. [DOI: 10.3389/fendo.2022.980582] [Reference Citation Analysis]
11 Saltiki K, Simeakis G, Karapanou O, Alevizaki M. MANAGEMENT OF ENDOCRINE DISEASE: Medullary thyroid cancer: from molecular biology and therapeutic pitfalls to future targeted treatment perspectives. Eur J Endocrinol 2022;187:R53-63. [PMID: 35895692 DOI: 10.1530/EJE-22-0312] [Reference Citation Analysis]
12 Yi Q, Peng J, Xu Z, Liang Q, Cai Y, Peng B, He Q, Yan Y. Spectrum of BRAF Aberrations and Its Potential Clinical Implications: Insights From Integrative Pan-Cancer Analysis. Front Bioeng Biotechnol 2022;10:806851. [DOI: 10.3389/fbioe.2022.806851] [Reference Citation Analysis]
13 Sengun S, Korkmaz H, Ciris M, Yüceer RO, Boyluboy SM, Kiran M. Diagnostic and prognostic value of Stanniocalcin 1 expression in papillary thyroid cancer. Endocrine 2022. [PMID: 35788886 DOI: 10.1007/s12020-022-03126-4] [Reference Citation Analysis]
14 Huang W, Hao Z, Mao F, Guo D. Small Molecule Inhibitors in Adult High-Grade Glioma: From the Past to the Future. Front Oncol 2022;12:911876. [DOI: 10.3389/fonc.2022.911876] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Ragusa F, Ferrari SM, Elia G, Paparo SR, Balestri E, Botrini C, Patrizio A, Mazzi V, Guglielmi G, Foddis R, Spinelli C, Ulisse S, Antonelli A, Fallahi P. Combination Strategies Involving Immune Checkpoint Inhibitors and Tyrosine Kinase or BRAF Inhibitors in Aggressive Thyroid Cancer. Int J Mol Sci 2022;23:5731. [PMID: 35628540 DOI: 10.3390/ijms23105731] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
16 Wang Y, Yang L, Mao L, Zhang L, Zhu Y, Xu Y, Cheng Y, Sun R, Zhang Y, Ke J, Zhao D. SGLT2 inhibition restrains thyroid cancer growth via G1/S phase transition arrest and apoptosis mediated by DNA damage response signaling pathways. Cancer Cell Int 2022;22:74. [PMID: 35148777 DOI: 10.1186/s12935-022-02496-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
17 Pitoia F, Jerkovich F, Trimboli P, Smulever A. New approaches for patients with advanced radioiodine-refractory thyroid cancer. World J Clin Oncol 2022; 13(1): 9-27 [DOI: 10.5306/wjco.v13.i1.9] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
18 Dabravolski SA, Nikiforov NG, Zhuravlev AD, Orekhov NA, Mikhaleva LM, Orekhov AN. The Role of Altered Mitochondrial Metabolism in Thyroid Cancer Development and Mitochondria-Targeted Thyroid Cancer Treatment. Int J Mol Sci 2021;23:460. [PMID: 35008887 DOI: 10.3390/ijms23010460] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
19 Zeng L, Yuan S, Zhou P, Gong J, Kong X, Wu M. Circular RNA Pvt1 oncogene (CircPVT1) promotes the progression of papillary thyroid carcinoma by activating the Wnt/β-catenin signaling pathway and modulating the ratio of microRNA-195 (miR-195) to vascular endothelial growth factor A (VEGFA) expression. Bioengineered 2021;12:11795-810. [PMID: 34927541 DOI: 10.1080/21655979.2021.2008639] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
20 Wang H, Yu Y, Wang K, Sun H. Bibliometric Insights in Advances of Anaplastic Thyroid Cancer: Research Landscapes, Turning Points, and Global Trends. Front Oncol 2021;11:769807. [PMID: 34900720 DOI: 10.3389/fonc.2021.769807] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
21 Chen H, Song A, Wang Y, He Y, Tong J, Di J, Li C, Zhou Z, Cai X, Zhong D, Da J. BRAFV600E mutation test on fine-needle aspiration specimens of thyroid nodules: Clinical correlations for 4600 patients. Cancer Med 2022;11:40-9. [PMID: 34851044 DOI: 10.1002/cam4.4419] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
22 Wang Y, Zhang L, Qi L, Yi X, Li M, Zhou M, Chen D, Xiao Q, Wang C, Pang Y, Xu J, Deng H, Liu L, Guan X. Machine Learning: Applications and Advanced Progresses of Radiomics in Endocrine Neoplasms. J Oncol 2021;2021:8615450. [PMID: 34671399 DOI: 10.1155/2021/8615450] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
23 Zhang J, Luo D, Li F, Li Z, Gao X, Qiao J, Wu L, Li M. Ginsenoside Rg3 Alleviates Antithyroid Cancer Drug Vandetanib-Induced QT Interval Prolongation. Oxid Med Cell Longev 2021;2021:3520034. [PMID: 34659631 DOI: 10.1155/2021/3520034] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
24 Zhang L, Xu S, Cheng X, Wu J, Wu L, Wang Y, Wang X, Bao J, Yu H. Curcumin induces autophagic cell death in human thyroid cancer cells. Toxicol In Vitro 2021;78:105254. [PMID: 34634291 DOI: 10.1016/j.tiv.2021.105254] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
25 Ding Y, Han X, Sun Z, Tang J, Wu Y, Wang W. Systemic Sequential Therapy of CisGem, Tislelizumab, and Lenvatinib for Advanced Intrahepatic Cholangiocarcinoma Conversion Therapy. Front Oncol 2021;11:691380. [PMID: 34527576 DOI: 10.3389/fonc.2021.691380] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
26 Li K, Yao T, Zhang Y, Li W, Wang Z. NEAT1 as a competing endogenous RNA in tumorigenesis of various cancers: Role, mechanism and therapeutic potential. Int J Biol Sci 2021;17:3428-40. [PMID: 34512157 DOI: 10.7150/ijbs.62728] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 6.5] [Reference Citation Analysis]
27 Liao X, Liu Z, Song H. Thyroid dysfunction related to vascular endothelial growth factor receptor tyrosine kinase inhibitors: A real-world study based on FAERS. J Clin Pharm Ther 2021. [PMID: 34169545 DOI: 10.1111/jcpt.13472] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
28 Gimm O, Ivansson K, Beka E, Rossitti HM, Garvin S, Söderkvist P. Increased diagnostic sensitivity of palpation-guided thyroid nodule fine-needle aspiration cytology by BRAF V600E-mutation analysis. J Pathol Clin Res 2021. [PMID: 34156770 DOI: 10.1002/cjp2.231] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
29 Pregel P, Scala E, Bullone M, Martano M, Nozza L, Garberoglio S, Garberoglio R, Bollo E, Scaglione FE. Radiofrequency Thermoablation On Ex Vivo Animal Tissues: Changes on Isolated Swine Thyroids. Front Endocrinol (Lausanne) 2021;12:575565. [PMID: 34177792 DOI: 10.3389/fendo.2021.575565] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
30 Qi Y, He J, Zhang Y, Wang L, Yu Y, Yao B, Tian Z. Circular RNA hsa_circ_0001666 sponges miR‑330‑5p, miR‑193a‑5p and miR‑326, and promotes papillary thyroid carcinoma progression via upregulation of ETV4. Oncol Rep 2021;45:50. [PMID: 33760216 DOI: 10.3892/or.2021.8001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
31 Grimm D. Cell and Molecular Biology of Thyroid Disorders 2.0. Int J Mol Sci 2021;22:1990. [PMID: 33671462 DOI: 10.3390/ijms22041990] [Reference Citation Analysis]